This study was designed to determine if induction of anaesthesia with etomidate titrated to an early EEG burst suppression pattern would produce minimal changes in cerebral perfusion pressure, and prevent increases in intracranial pressure (ICP) associated with tracheal intubation~ Eight patients, 
from induction to burst suppression was associated with a 50% decrease in ICP (22 --+ 1 vs 11 +_. 1 mmHg, P < 0.01), but there were no changes in MAP, CPP, or HR. The decrease in ICP was maintained during the first 30 sec and the following 60 sec after intubation as MAP and HR remained unchanged. Our results suggest that when etomidate was administered to early burst suppression pattern on EEG, minimal changes in CPP occurred during induction of anaesthesia and a marked reduction in ICP was maintained following tracheal intubation.

Cette ~tude a ~td entreprise afin de ddterminer si l'induction de l' anesth~sie avec l'~tomidate, dos~ pour provoquer un d~but de suppression des ondes it I'EEG, produirait des changements minimes de la pression de la perfusion c~rdbrale, et pr#viendrait les augmentations de tension intracr,~nienne (ICP) associ~es it l'intubation endotrach~ale. Huit patients agds de 18 it 71 ans et avec une l~sion intracrdnienne expansive, ont dt# #tudids. Dans chaque cas, la tension intracranienne, #tait surveillde it l'aide d'un catheter insdr~ avant la chirugie it l'aide d'une ventriculostomie lat~rale. Apr~s l'installation en salle d'opdration d'un ECG, d'une ligne art#rielle radiale et d'un EEG informatis~ ~ deux canaux, des mesures de contr61e (it l '~tat d'~veil) de la tension art~rielle moyenne (MAP) (mmHg), de la pression de la perfusion c~r~brale (CPP) (mmHg), de la fr~quence cardiaque (HR-bpm), de la puissance de l 'EEG (picowatts-p W) et de la frdquence de l'extr~mit# du spectre (~ spectral edge ~) (SEF, Hz) #tait obtenues. L'anesth~sie dtait induite avec l'~tomidate ~ raison de 0,2 mg 9 kg -t iv, suivie d'une perfusion
In patients with intracranial space-occupying lesions, control of mean arterial (MAP) and intracranial (ICP) pressure during anaesthetic induction and tracheal intubation is essential to prevent an untoward increase or decrease in cerebral perfusion pressure (CPP --MAP -ICP). Although thiopentone produces very favourable decreases in cerebral blood flow (CBF) and cerebral metabolic rate for oxygen (CMRO2), t large doses (4-6 mg.kg -I iv) are required to decrease ICP during induction and intubation. This "deep" level of barbiturate anaesthesia often produces marked decreases in MAP and CPP in these patients who are usually hypovolaemic as a result of fluid restriction and diuretic therapy. This decrease in MAP and CPP produced by thiopentone may result in compromised regional cerebral blood flow (rCBF). 2 Conversely, "lighter" anaesthetic levels using smaller amounts (2-3 nag-kg -l) of thiopentone will usually not attenuate the increases in MAP and CPP produced during laryngoscopy with tracheal intubation. 3 Large increases in CPP can either increase intracranial blood volume, thereby increasing ICP, or disrupt the blood-brain-barrier (BBB), causing cerebral oedema. 4 Etomidate produces comparable decreases in rCBF, CMRO2, 5'6 and ICP 7 as thiopentone. However, in contrast to the ultra-short-acting barbiturates, the usual induction doses (0.2-0.3 mg-kg -I iv) of etomidate produce these effects with minimal alterations in MAP or CPP. 8 Similar electroencephalographic (EEG) changes have been observed following increasing doses of both induction agents.9'l~ A close relationship between etomidate blood concentrations and EEG changes has been demonstrated with a minimal time lag between peak serum concentration and effect. 9'11'12 Thus, in contrast to the wide intersubject variability found for dose-response relationships, a closer association between the dose of etomidate administered and its resultant EEG changes can be demonstrated.~2 The following study was designed to determine if induction of deep anaesthesia with etomidate, defined by an early burst suppression pattern on EEG, would decrease ICP while producing minimal changes in CPP during anaesthetic induction, and prevent the large increases in CPP and ICP after laryngoscopy and tracheal intubation. 
Methods
Following approval of the study protocol by the Institutional Review Board of the Washington University School of Medicine, eight consenting ASA Ill-IV patients undergoing surgery for intracranial space-occupying lesions were studied (Table I) . Their ages ranged from 18-71 yr and each was receiving dexamethasone, 4 mg iv every six hours. Before surgery, each patient had a lateral ventriculostomy catheter placed by the neurosurgical service for clinical and computerized tomographic (CT) scan evidence of increased ICP. Exclusion criteria included treatment with beta-adrenergic antagonists, calcium-channel antagonists, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, pregnancy, allergy to the study drugs, a functioning ventriculo-atrial or peritoneal shunt, and a history of ethanol or drug abuse. All patients were within 20% of ideal body weight (kg).
Each patient received oral premedication with ranitidine, 150 mg, and metoclopramide, 10 mg, 1-2 hr before surgery. Upon arrival in the operating room, all patients were monitored with an ECG, automatic oscillometric blood pressure (BP) cuff (Dinamap~), pulse oximeter (Ohmeda ~ 3710), and mass spectrometer (Ohmeda ~ 6000 Multi-Gas Monitor). A peripheral iv catheter was then inserted using local anaesthesia and a 20-gauge radial arterial catheter was placed following the administration of fentanyl, 50-75 p,g iv. Both the lateral ventriculostomy and radial arterial catheters were connected to pressure transducers (Sorenson Transpac ~, #42590-01) and the pressures were recorded continuously (Mennen Horizon ~, model #250) following calibration.
Throughout the study period, a computerized EEG monitor (Interspec-Neurotrac~), with raw (scalp) EEG, compressed spectral array (CSA), and EEG power spectrum capabilities was employed, using a 0.5 to 30 Hz amplifier bandpass and a 128 Hz digitizing frequency. Five subdermal, fine-gauge platinum needle electrodes (Grass ~) were placed in a symmetrical frontal-temporal montage as follows. A ground electrode was placed in the middle of the forehead just superior to the nasion. Chan- (2) is shown followed by a return towards EEG suppression (3). (C) Raw EEG tracing recorded four minutes later is consistent with a relatively "lighter" depth of anesthesia. nels 1 and 2 were connected by their positive (G2) terminals to left and right electrodes, placed on each side of the forehead at the lateral hairline. In addition, these two channels were connected by their negative (G 1) terminals to left and right electrodes, placed on or posterior to the mastoid (this corresponds to F7-T s, Fs-T 6, in the international 10-20 system). Interelectrode distance was at least 10 cm, and interelectrode impedence was 3 kOhms or less. In order to produce and record satisfactory scalp EEG tracings, a sensitivity (gain) of 30--40 microvolts I~v) was employed. EEG power (picowatts-pW) was obtained using fast-Fourier analysis which digitizes the raw EEG signal over a 2-see epoch into its component sine waves. Squaring the amplitudes of the individual sine waves generates the EEG power spectrum in each channel. The EEG power values from the two channels were combined and averaged for each two-second epoch for a total of 15 epochs. The CSA display mode presents the power spectrum concisely in the form of a three-dimensional graph. With frequency of 1 to 30 Hz as the x-axis, the resultant CSA with spectral edge frequency (SEF) was then displayed in 2-sec epochs. The SEF marker (Hz) represents the frequency below which 95% of the EEG power is located.
Control (awake) measurements of MAP, ICP, CPP, HR, EEG power, and SEF were obtained just before anaesthetic induction and CPP was calculated. These six baseline variables were measured during a period of low patient stimulation and were stable for at least one min prior to their recording. With each patient receiving 100% oxygen (02) by mask, anaesthesia was induced with etomidate, 0.2 mg. kg -1 iv, followed by a continuous iv etomidate infusion at a rate of 20 mg-min -I. During the study, continuous scalp (raw) EEG, EEG power, and CSA with SEF recordings were obtained and interpreted by an anaesthe- tist who was unaware of the etomidate dose administered. When there was no response to verbal and tactile stimulation, vecuronium 0.2 mg. kg -I iv, was given, and ventilation was controlled by mask using 100% O 2 to maintain end-tidal PCO 2 of 35-40 mmHg with an 02 saturation of 98-100%. From the start of induction until an early EEG burst suppression pattern was reached, the lowest values for MAP, ICP, CPP, HR, EEG power, and SEF were recorded. If >30% decrease in MAP occurred during this time, the etomidate infusion was to be stopped, and ephedrine, 5-10 mg iv, given. When an early burst suppression pattern, characterized by an isoelectric raw EEG separated by 1-2-sec bursts of electrical activity recorded at a sensitivity of 30-40 Ixv', was achieved ( Figure) , the etomidate infusion was stopped, tracheal intubation performed, and 100% 02 administered. The highest values for MAP, ICP, CPP, HR, EEG power, and SEF were recorded during the first 30 sec immediately after laryngoscopy and intubation. The peak values of these six variables were again recorded during the following 60 sec. If >30% increase in MAP occurred shortly after intubation, it was treated with labetalol 5 mg iv. The time from the initial etomidate bolus until burst suppression occurred was noted, as was the total dose of etomidate required to reach burst suppression. In addition, the durations of laryngoscopy and burst suppression were recorded. When burst suppress ion was no longer present, maintenance of anaesthesia using controlled ventilation was begun with nitrous oxide 60-70% (N20) in O 2, isoflurane (0.1-0.3% end-tidal), and a fentanyl infusion (1-2 I~g" kg -l" hr-l).
All measures are reported as mean + SE. The findings for MAP, ICP, CPP, HR, EEG power, and SEF recorded during the periods of: (1) induction to burst suppression; (2) 1-30 sec following intubation; and (3) 31-90 see following intubation, were compared with their control (awake) measurements using analysis of variance with repeated measures. A P < 0.05 was considered significant.
Results
The mean age and weight of the eight patients studied were 39 -+ 9 yr and 58 -+ 5 kg, respectively. The MAP, ICP, CPP, HR, EEG power, and SEF findings are summarized in Table II . Compared with the awake control measures, the period from induction to burst suppression was associated with -->50% decreases in ICP (22 -+ 1 vs 11 _+ 1 mmHg, P < 0.01), EEG power (94 _ 8 vs 25 _ 8 pW, P < 0.01), and SEF (23 _+ 1 vs 12 _+ 1 Hz, P < 0.01), but did not produce any changes in MAP or HR. These decreases in ICP, EEG power, and SEF were maintained during the first 30 sec and the subsequent 60 sec after intubation as MAP and HR remained unchanged. The findings for ICP and MAP resulted in increases in CPP during the period from induction to burst suppression (72 __ 2 vs 82 _+ 2 mmHg, P < 0.01) plus the 30-and subsequent 60-sec (72 _+ 2 vs 83 ___ 2 mmHg, P < 0.01) measurement periods after intubation, when these values for CPP were compared with awake controls. However, further analysis did not reveal any changes in these 90-sec post-intubation CPP values (78 _ 2 vs 82-83 _ 2 mmHg, P = NS) when they were compared with the lowest CPP recorded during the period from induction to burst suppression. None of the patients required treatment for increases or decreases in MAP > 30% during either induction of anaesthesia or following tracheal intubation.
Burst suppression on EEG was reached in 240 _ 33 sec and its duration was 211 _ 25 sec (Table III) . Duration of laryngoscopy was 20 -1.8 sec. The etomidate dose required to reach burst suppression was 1.28 _ 0.11 mg. kg -1.
Discussion
Except for ketamine, 13A4 all iv anaesthesia induction agents decrease ICP. 7'15-17 Unfortunately, aside from etomidate, 7 the dosages required to decrease ICP often produce large decreases in MAP that can lead to considerable reductions in CPP 2'16"17 which may jeopardize collat-eral blood supply to ischaemic regions of the brain. Conversely, tracheal intubation in patients with reduced intracranial compliance (e.g., tumour, haemorrhage, etc.) commonly produces large increases in ICP and CPP which can lead to a worsening of neurological status. Unfortunately, the efficacy of all anaesthetic induction agents, including etomidate in the usual (0.2-0.3 mg.kg -1) dosage, in preventing an increase in ICP during laryngoscopy and intubation has not been demonstrated. 2'7'13'15-t7 In our report, using a standard etomidate induction dose followed by a controlled infusion, ICP decreased and CPP was maintained throughout induction. These results were not surprising and are consistent with earlier findings for etomidate. 7'18'19 However, more importantly, using an early burst suppression pattern on EEG as the endpoint for etomidate administration as well as an indicator of "deep anaesthesia," we were able to maintain a marked reduction in ICP following laryngoscopy and intubation. Furthermore, compared with the findings recorded during the period from induction to burst suppression, this etomidate-induced EEG effect also prevented an intubation-associated increase in CPP while probably producing favourable decreases in CMRO 2 and CBF. 5, 20 Because the EEG is an indicator of the electrical activity of the cerebral cortex, it may provide a continuous, sensitive measure of the degree of drug-induced cerebral depression (depth of anaesthesia) prior to noxious stimuli. If so, the degree of EEG depression may then be used to predict the magnitude of the intracranial and/or haemodynamic pressure response following laryngoscopy and endotracheal intubation. However, previous attempts at correlating various EEG measures and haemodynamic responses have yielded inconsistent results. 12'21-23 The inconsistent findings for the SEF may be related to its large decline during light levels of anaesthesia which overshadows its subsequent decreases during deepening of anaesthesia. 12.23 Thus, the compression of the EEG voltage waveform produced by the SEF is at the expense of information regarding the slower EEG waveforms more prevalent at the deeper levels of anaesthesia. 2!' 23 Arden et al. t2 found the median EEG frequency to be a better measure of etomidate's EEG effects. Unfortunately, they also frequently saw hypertension which was not associated with EEG signs of arousal. Finally, in a recent report 23 using a sufentanil infusion for induction, failure to respond to verbal commands was found to coincide with a ceiling effect for various processed EEG variables (SEF, mean frequency, power spectrum), and little further changes in EEG activity were demonstrated despite the continued deepening of anaesthesia with sufentanil.
It is possible that the intracranial and haemodynamic responses to stimuli like tracheal intubation are more Previous studies demonstrated that there is no simple method to maintain a decreased ICP (compared with its awake baseline value) immediately following laryngoscopy and tracheal intubation in patients with intracranial hypertension. Although thiopentone, 2 lidocaine, 25 and propofo117 are all beneficial in attenuating the increase in ICP secondary to tracheal stimulation, none has been shown to maintain a decreased ICP effectively soon after intubation. In our report, using early EEG burst suppression as the endpoint for etomidate administration, a large reduction in ICP occurred which, to our knowledge, was maintained for the first time following laryngoscopy and intubation. In addition, our controlled method of etomidate administration probably also contributed to the prevention of an induction-associated fall in CPP, a problem frequently encountered with other commonly employed iv anaesthetic induction agents which lower ICP, especially when administered in a bolus fashion. 2 ' 16"17"26 In summary, when etomidate was administered tO an early EEG, burst suppression pattern ICP was decreased and minimal changes in CPP occurred during induction of anaesthesia. Using this EEG pattern as an indicator of "deep anaesthesia" the reduction in ICP was maintained after laryngoscopy and tracheal intubation. This EEG-based model for etomidate administration may represent an improved anaesthetic induction technique for patients with intracranial hypertension.
